DNA demethylation caused by 5-Aza-2'-deoxycytidine induces mitotic alterations and aneuploidy
Related Experiment Video
Updated: Mar 27, 2026

Immunohistochemical Detection of 5-Methylcytosine and 5-Hydroxymethylcytosine in Developing and Postmitotic Mouse Retina
Published on: August 29, 2018
Giuseppe Costa1, Viviana Barra1, Laura Lentini1
1Dipartimento di Scienze e Tecnologie Biologiche, Chimiche e Farmaceutiche (STEBICEF), Università degli Studi di Palermo, Palermo, Italy.
Abstract:
Aneuploidy, the unbalanced number of chromosomes in a cell, is considered a prevalent form of genetic instability and is largely acknowledged as a condition implicated in tumorigenesis. Epigenetic alterations like DNA hypomethylation have been correlated with cancer initiation/progression. Furthermore, a growing body of evidence suggests the involvement of epigenome-wide disruption as a cause of global DNA hypomethylation in aneuploidy generation.Here, we report that the DNA hypomethylating drug 5-aza-2'-deoxycytidine (DAC), affects the correct ploidy of nearly diploid HCT-116 human cells by altering the methylation pattern of the chromosomes. Specifically, we show that a DAC-induced reduction of 5-Methyl Cytosine at the pericentromeric region of chromosomes correlates with aneuploidy and mitotic defects.Our results suggest that DNA hypomethylation leads to aneuploidy by altering the DNA methylation landscape at the centromere that is necessary to ensure proper chromosomes segregation by recruiting the proteins necessary to build up a functional kinetochore.
Insights
DNA hypomethylation, induced by 5-aza-2'-deoxycytidine (DAC), disrupts chromosome segregation and causes aneuploidy (abnormal chromosome numbers). This occurs by altering centromeric methylation patterns essential for kinetochore formation.
Area of Science:
- Genetics
- Epigenetics
- Cell Biology
Background:
- Aneuploidy, an abnormal chromosome number, is a hallmark of genetic instability and implicated in cancer.
- Epigenetic changes, particularly DNA hypomethylation, are linked to cancer development and progression.
- Evidence suggests epigenome-wide disruption contributes to DNA hypomethylation and aneuploidy.
Purpose of the Study:
- To investigate the effect of the DNA hypomethylating drug 5-aza-2 -deoxycytidine (DAC) on chromosome ploidy.
- To explore the relationship between DAC-induced DNA hypomethylation and aneuploidy in human cells.
Main Methods:
- Treatment of nearly diploid HCT-116 human cells with DAC.
- Analysis of DNA methylation patterns, specifically 5-Methyl Cytosine levels.
- Assessment of chromosome ploidy and mitotic defects.
Main Results:
- DAC treatment reduced 5-Methyl Cytosine levels at the pericentromeric regions of chromosomes.
- This reduction in methylation correlated with the occurrence of aneuploidy and mitotic defects.
- DNA hypomethylation at the centromere disrupts kinetochore assembly and proper chromosome segregation.
Conclusions:
- DNA hypomethylation can directly lead to aneuploidy by altering centromeric epigenetic landscapes.
- Proper chromosome segregation relies on centromeric methylation for functional kinetochore assembly.
- Targeting DNA methylation may offer new avenues for cancer therapy by preventing aneuploidy.
Related Concept Videos
Nondisjunction
Nondisjunction
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Meiosis vs. Mitosis
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
Spontaneous and Induced Mutations

